These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8249121)

  • 1. Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats.
    Whitley WD; Hancock WW; Kupiec-Weglinski JW; DeSousa M; Tilney NL
    Transplantation; 1993 Nov; 56(5):1182-8. PubMed ID: 8249121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN; Maguire JA; Hancock WW
    Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival.
    Hancock WW; Whitley D; Kupiec-Weglinski JW; Tilney NL
    Transplant Proc; 1992 Feb; 24(1):214-5. PubMed ID: 1539252
    [No Abstract]   [Full Text] [Related]  

  • 5. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
    Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
    J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
    Hancock WW; Sayegh MH; Sablinski T; Kut JP; Kupiec-Weglinski JW; Milford EL
    Transplantation; 1992 Jun; 53(6):1276-80. PubMed ID: 1604485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide prolonged graft survival in a rat cardiac transplant model but had no inhibitory effect on lymphocyte function in vitro.
    Ostraat O; Riesbeck K; Qi Z; Eriksson T; Schatz H; Ekberg H
    Transpl Immunol; 1996 Jun; 4(2):117-25. PubMed ID: 8843588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
    Boyle MJ; Dumble LJ
    Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide pretreatment of cyclosporine-treated rats enhances cardiac allograft survival.
    Lin H; Wei RQ; Bolling SF
    J Surg Res; 1993 Oct; 55(4):441-5. PubMed ID: 8412131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
    Shen Z; Pelletier S; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
    J Heart Lung Transplant; 1996 Oct; 15(10):1034-8. PubMed ID: 8913921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation.
    Kataoka M; Margenthaler JA; Ku G; Flye MW
    J Immunol; 2003 Jul; 171(1):204-11. PubMed ID: 12816999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats.
    Shibasaki S; Yamashita K; Goto R; Oura T; Wakayama K; Hirokata G; Shibata T; Igarashi R; Haga S; Ozaki M; Todo S
    Transpl Immunol; 2012 Jan; 26(1):42-9. PubMed ID: 22019622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines.
    Heidecke CD; Hancock WW; Westerholt S; Sewczik T; Jakobs F; Zantl N; Varzaru A; Siegling A; Kurrle R; Deusch K; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(6):948-56. PubMed ID: 8623165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.